GLP-1 drugs (weight loss medications) will be 'Tech of the Year' for 2024 because the obesity/diabetes economy represents $1.7 trillion (~8% of US economy), and declining obesity rates will cascade into massive impacts across consumer companies (McDonald's, PepsiCo, Coca-Cola), kidney dialysis companies, medical equipment manufacturers, and mobility device producers.
forecastpending
Speaker
Scott GallowayEvidence Quote
“the diabetes or the Obesity economy is $1.7 trillion it's I mean what is that that's like 8% of the economy”
Source
Breaking Down 2024 Predictions + Audience Comments and Pushback | Prof G Markets— Prof G MarketsCreated: 8/12/2026, 6:02:34 PM
My Notes
Loading notes...